Cited by 45Alzheimer's disease research and treatmentsMedicinal Plants and NeuroprotectionDementia and Cognitive Impairment Research

Novel Nutraceutical Compounds in Alzheimer Prevention

Open access
Maccioni, Ricardo Benjamin, Calfío, Camila, González, Andrea, Lüttges, Valentina·2022·Biomolecules

Abstract

Alzheimer’s disease (AD) incidence is increasing worldwide at an alarming rate. Considering this increase, prevention efforts, stemming from scientific research, health education, and public policies, are critical. Clinical studies evidenced that healthy lifestyles along with natural multitarget and disease-modifying agents have a preventative impact on AD or mitigate symptoms in diagnosed patients. The pathological alterations of AD start 30 years before symptoms, and it is essential to develop the capacity to detect those changes. In this regard, molecular biomarkers that detect early pathological manifestations are helpful. Based on markers data, early preventive interventions could reduce more than 40% of AD cases. Protective actions include exercise, shown to induce neurogenesis, cognitive stimulation, intellectual-social activity, and nutrition among others. Mediterranean diet, preprobiotics, and nutraceuticals containing bioactive molecules with antioxidant and anti-inflammatory properties are relevant. Antiprotein aggregation molecules whose mechanisms were described are important. Anti-inflammatory agents with anti-aggregation properties that help to control cognitive impairment, include quercetin, biocurcumin, rosemarinic acid, and Andean shilajit. Anthocyanidins, e.g., delphinidin, malvidin, and natural flavonoids, are also included. Quercetin and hydroxy-tyrosol are antiaging molecules and could have anti-AD properties. We emphasize the relevance of nutraceuticals as a main actor in the prevention and/or control of dementia and particularly AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom12020249

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Natural formulas with anti-inflammatory activity have been developed to treat AD.

    “In addition, natural formulas with anti-inflammatory activity have been developed to treat AD.543”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [543]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. [17]Essa M.M. Akbar M. Guillemin G. The Benefits of Natural Products for Neurodegenerative Diseases, 1 ed. Springer Cham, Switzerland 2016 496
  2. [19]Gupta R.C. Lall R. Srivastava A. Nutraceuticals Efficacy, Safety and Toxicity 2nd ed. Academic Press Cambridge, MA, USA 2021 1396

Cited by

Sorted by citations

Authors
Maccioni, R. B., Calfío, C., González, A., & Lüttges, V.
Affiliations
University of Chile (CL)
Corresponding author
Maccioni, Ricardo Benjamin
Venue
Biomolecules
Publisher
MDPI AG
Published
2022-02-03
Volume
12
Issue
2
Pages
249
ISSN
2218-273X (ISSN-L)
OpenAlex
W4210560908
Cited by
45
References
87
Citations by year
2026: 3 · 2025: 7 · 2024: 12 · 2023: 17 · 2022: 6
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Agencia Nacional de Investigación y Desarrollo (i7819020001, ID19I10301)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, nutraceuticals, Alzheimer's disease prevention, Mediterranean diet, bioactive compounds, antioxidant activity, anti-inflammatory agents, protein aggregation, quercetin, Shilajit, anthocyanidins, flavonoids, hydroxytyrosol, early biomarkers, dementia, physical activity, cognitive stimulation, nutrition
MeSH terms
Alzheimer Disease, Antioxidants, Humans, Dietary Supplements, Diet, Mediterranean, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review